Medical device reimbursement refers to the process by which manufacturers, healthcare providers, and patients obtain financial coverage for medical devices from payers (government, insurers, or health funds).
Crucial for market access and commercial success, an effective reimbursement strategy considers national healthcare policies, clinical benefits, cost-effectiveness, and the product’s classification within existing reimbursement systems.
In our 5-minute guide below, our Executive Board Member Jörg Dogwiler and esteemed partner Dr Stefan Walzer, CEO of MArS, share an overview of the main reimbursement pathways for the EU & US, and some practical advice for overcoming the challenges.
Do you have a medical device reimbursement challenge? Get in touch to speak with our team of experts.
